Biosimilars: A New Generation of Biologics - Image 1

£85.76

Springer Biosimilars: A New Generation of Biologics

Name: Biosimilars: A New Generation of Biologics
Brand: Springer
Price: 85.76 GBP
Availability: InStock

Medical Technology

It has never been this cheap. We have no record of a lower price.

£86 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days · 74 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 74 days • 1 price levels

Days at Price

Price Analysis

Most common price: £86 (74 days, 100.0%)

Price range: £86 - £86

Price levels: 1 different prices over 74 days

Description

Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 2817803353
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Medical Technology
Domain: Amazon UK
Release Date: 21 November 2012
Listed Since: 24 March 2012

Barcode

No barcode data available

Springer Biosimilars: A New Generation of Biologics

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars: A New Generation of Biologics

Biosimilars Development Strategies: Fast to Market Approaches

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

ASHP Biosimilars and Biologics - Implementation and Monitoring

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

Biosimilarity: The FDA Perspective - CRC Press Book

CRC Press - Biosimilar Drug Product Development Book

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Biologics, Biosimilars, and Biobetters: An Introduction for Pharmacists, Physicians and Other Health Practitioners

Follow-On Biologics: Background & Issues (Biotechnology in Agriculture Industry and Medicine)

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value

Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Biopharmaceuticals, an Industrial Perspective

Biopharmaceuticals, an Industrial Perspective

Principles of Biomedical Sciences and Industry: Translating Ideas into Treatments

Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)